8 Pharma Stocks in Good Health

The health care sector is a field that will continue to grow as long as Baby
Boomers continue to get old and retire. And, since that trend isnt going to end
anytime soon, I expect the trend to continue well into the decade. However, its
up to savvy investors to take advantage of the plays that big pharma offers
some of which can be found below. I watch more than 5,000 publicly traded
companies with my Portfolio Grader tool, ranking companies by a number of
fundamental and quantitative measures. This week, Ive got eight Pharma stocks to
buy. Here they are, in alphabetical order. Each one of these stocks gets an
"A" or "B" according to my research, meaning it is a "strong buy" or
"buy." Abbott Laboratories (NYSE: ABT ) discovers, develops, manufactures
and sells various health care products. ABT stock is up almost 16% in the last
12 months. ABT gets an "A" for return on equity in my Portfolio Grader tool.
For more information, view my complete analysis of ABT stock . Bristol Myers
Squibb (NYSE: BMY ) sells its health care products to wholesalers, retail
pharmacies, hospitals, government entities and other medical providers. In the
last year, BMY stock has climbed 33% compared to a 6% gain for the Dow Jones in
the same period. BMY gets a "B" for earnings momentum, a "B" for the
magnitude in which earnings projections have increased over the past month and
an "A" for return on equity in my Portfolio Grader tool. For more
information, view my complete analysis of BMY stock . Eli Lilly (NYSE: LLY ) is
involved with every process of development and sale for its pharmaceutical
products. LLY stock has jumped 14 % in the last year, compared to smaller gains
by the broader markets. LLY gets a "B" for cash flow and an "A" for
return on equity in my Portfolio Grader tool. For more information, view my
complete analysis of LLY stock . GlaxoSmithKline (NYSE: GSK ) is best known for
developing vaccines, over-the-counter medicines and health-related consumer
products. A 14% has made GSK stock a success in the last year. GSK gets an
"A" for earnings momentum and an "A" for return on equity in my
Portfolio Grader tool. For more information, view my complete analysis of GSK
stock . Johnson & Johnson (NYSE: JNJ ) has become a household name for
developing a range of products in the health care field. JNJ stock is up 4% in
the last 12 months. JNJ gets a "B" for earnings momentum and an "A" for
return on equity in my Portfolio Grader tool. For more information, view my
complete analysis of JNJ stock . Merck (NYSE: MRK ) is involved with
prescription medicines, vaccines, biologic therapies, animal health and consumer
care products.